These novel therapies , Tirzepatide , represent a remarkable advancement in addressing metabolic dysfunction and potentially associated conditions . They all are classified as GLP-1 receptor https://neilodsr265367.shoutmyblog.com/40146083/tirzepatide-a-thorough-dive-into-metabolic-copyright